Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 1
1967 1
1969 1
1971 1
1972 1
1973 3
1974 2
1975 1
1976 3
1977 1
1978 3
1979 4
1980 1
1981 2
1982 1
1983 3
1984 4
1985 6
1986 3
1987 3
1988 10
1990 4
1991 3
1992 6
1993 6
1994 9
1995 9
1996 4
1997 7
1998 6
1999 9
2000 12
2001 10
2002 10
2003 14
2004 17
2005 14
2006 15
2007 12
2008 17
2009 23
2010 20
2011 19
2012 23
2013 34
2014 30
2015 36
2016 36
2017 37
2018 44
2019 48
2020 31
2021 33
2022 50
2023 30
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

675 results

Results by year

Filters applied: . Clear all
Page 1
Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.
Jany B, Welte T. Jany B, et al. Dtsch Arztebl Int. 2019 May 24;116(21):377-386. doi: 10.3238/arztebl.2019.0377. Dtsch Arztebl Int. 2019. PMID: 31315808 Free PMC article. Review.
Pleural fluid puncture (pleural tap) enables the differentiation of a transudate from an exudate, which remains, at present, the foundation of the further diagnostic work-up. ...Lung cancer is the most common cause of malignant pleural effusion,
Pleural fluid puncture (pleural tap) enables the differentiation of a transudate from an exudate, which remains, at present, t
Malignant Pleural Effusion: Presentation, Diagnosis, and Management.
Gayen S. Gayen S. Am J Med. 2022 Oct;135(10):1188-1192. doi: 10.1016/j.amjmed.2022.04.017. Epub 2022 May 14. Am J Med. 2022. PMID: 35576996 Review.
Malignant pleural effusions are common in patients with cancer. Most malignant pleural effusions are secondary to metastases to the pleura, most often from lung or breast cancer. ...Usually presenting as a large, unilateral exudative effusion, m
Malignant pleural effusions are common in patients with cancer. Most malignant pleural effusions are secondary t
Malignant Pleural Effusion: Diagnosis and Management.
Ferreiro L, Suárez-Antelo J, Álvarez-Dobaño JM, Toubes ME, Riveiro V, Valdés L. Ferreiro L, et al. Can Respir J. 2020 Sep 23;2020:2950751. doi: 10.1155/2020/2950751. eCollection 2020. Can Respir J. 2020. PMID: 33273991 Free PMC article. Review.
Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focused on the relief of symptoms. ...At present, the management of malignant pleural effusion has evolved towards less invasive app …
Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focuse …
Malignant Pleural Effusion and Its Current Management: A Review.
Skok K, Hladnik G, Grm A, Crnjac A. Skok K, et al. Medicina (Kaunas). 2019 Aug 15;55(8):490. doi: 10.3390/medicina55080490. Medicina (Kaunas). 2019. PMID: 31443309 Free PMC article. Review.
Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. ...It affects up to 15% of all patients with cancer and is the most common in lung, breast cancer, lymphoma, gynecological malignancies and malignant mesothel
Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. ...It affects up to 15% of all patients
ERS/EACTS statement on the management of malignant pleural effusions.
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA. Bibby AC, et al. Eur Respir J. 2018 Jul 27;52(1):1800349. doi: 10.1183/13993003.00349-2018. Print 2018 Jul. Eur Respir J. 2018. PMID: 30054348 Free article. Review.
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. ...The European Respiratory Society (ERS) and the European Association for Cardio-Thoracic Surgery (EACTS) established a multidisciplinary collab
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. ...Th
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.
Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, Iyer NP, Lee YCG, Lewis SZ, Maskell NA, Rahman NM, Sterman DH, Wahidi MM, Balekian AA. Feller-Kopman DJ, et al. Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-849. doi: 10.1164/rccm.201807-1415ST. Am J Respir Crit Care Med. 2018. PMID: 30272503
BACKGROUND: This Guideline, a collaborative effort from the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence-based recommendations to guide contemporary management of patients with a malignant pleural
BACKGROUND: This Guideline, a collaborative effort from the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic …
Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Dipper A, et al. Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3. Cochrane Database Syst Rev. 2020. PMID: 32315458 Free PMC article.
BACKGROUND: Malignant pleural effusion (MPE) is a common problem for people with cancer and usually associated with considerable breathlessness. ...OBJECTIVES: To ascertain the optimal management strategy for adults with malignant pleural effusion in t …
BACKGROUND: Malignant pleural effusion (MPE) is a common problem for people with cancer and usually associated with considerab …
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda MA, Klepetko W, Lacourt A, McElnay P, Maskell NA, Mutti L, Pairon JC, Van Schil P, van Meerbeeck JP, Waller D, Weder W, Cardillo G, Putora PM. Scherpereel A, et al. Eur Respir J. 2020 Jun 11;55(6):1900953. doi: 10.1183/13993003.00953-2019. Print 2020 Jun. Eur Respir J. 2020. PMID: 32451346 Free article.
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for Radiotherapy and Oncology (ESTRO) task force brought together experts to update previous 2009 ERS/ESTS guidelines on m …
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European Association for Cardio-Thoracic Surgery (EACTS) …
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Husain AN, Colby TV, Ordóñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR. Husain AN, et al. Arch Pathol Lab Med. 2018 Jan;142(1):89-108. doi: 10.5858/arpa.2017-0124-RA. Epub 2017 Jul 7. Arch Pathol Lab Med. 2018. PMID: 28686500 Free article.
CONTEXT: - Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. ...Selected molecular markers are now being used to distinguish benign from malignant mesothelial proliferations. These guidelines are meant to be a practical diagnostic r …
CONTEXT: - Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. ...Selected molecular markers are now …
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.
Wang Q, Xu C, Wang W, Zhang Y, Li Z, Song Z, Wang J, Yu J, Liu J, Zhang S, Cai X, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Li J, Liu B, Yuan J, Jiang Z, Lin G, Chen X, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Hu X, Zhou J, Zhu Z, Chen X, Pan W, Pang F, Zhang W, Jian Q, Wang K, Wang L, Zhu Y, Yang G, Lin X, Cai J, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Huang J, Wang X, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Hao Y, Wang Z, Wan B, Lv D, Yu J, Kang J, Zhang J, Zhang C, Wu L, Shi L, Ye L, Wang G, Wang Y, Gao F, Huang J, Wang G, Wei J, Huang L, Li B, Zhang Z, Li Z, Liu Y, Li Y, Liu Z, Yang N, Wu L, Wang Q, Huang W, Hong Z, Wang G, Qu F, Fang M, Fang Y, Zhu X, Du K, Ji J, Shen Y, Chen J, Zhang Y, Ma S, Lu Y, Song Y, Liu A, Zhong W, Fang W. Wang Q, et al. Thorac Cancer. 2023 Sep;14(26):2715-2731. doi: 10.1111/1759-7714.15022. Epub 2023 Jul 17. Thorac Cancer. 2023. PMID: 37461124 Free PMC article.
Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. ...The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caN
Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been incre
675 results